After Bad Data Comes Layoffs – Will The Next Job Cuts Be At Anthera?
Executive Summary
Anthera is exploring strategic alternatives after its lead drug candidate Sollpura failed in Phase III, which means layoffs may be coming soon. Several other biopharma companies have had to turn to job cuts already this year.